346 results on '"Sheridan M"'
Search Results
2. Development and evaluation of a BCI-neurofeedback system with real-time EEG detection and electrical stimulation assistance during motor attempt for neurorehabilitation of children with cerebral palsy
3. Exagamglogene Autotemcel: First Approval
4. Bosutinib: Pediatric First Approval
5. Correction to: Motixafortide: First Approval
6. Correction: Elacestrant: First Approval
7. Motixafortide: First Approval
8. Correction to: Rozanolixizumab: First Approval
9. Pozelimab: First Approval
10. Solriamfetol: A Review in Excessive Daytime Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnoea
11. Comparison of virtual reality to physical box and blocks on cortical an neuromuscualar activations in young adults
12. Rozanolixizumab: First Approval
13. 24 Benefit of therapeutic oral trials in dysphagia rehabilitation
14. Delandistrogene Moxeparvovec: First Approval
15. ClpP2 from Chlamydia trachomatis bound by MAS1-12
16. Endothelial structure contributes to heterogeneity in brain capillary diameter
17. Correction to: Eftrenonacog Alfa: A Review in Haemophilia B
18. Health Disparities in Appalachian and Other Rural Communities
19. Eftrenonacog Alfa: A Review in Haemophilia B
20. Take an individualized and multipronged approach when managing older adults with type 2 diabetes
21. Elacestrant: First Approval
22. Bexagliflozin: First Approval
23. Lecanemab: First Approval
24. Avacopan in granulomatosis with polyangiitis and microscopic polyangiitis: a profile of its use
25. Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis
26. Deucravacitinib: First Approval
27. 152 My patient has an unresolved CFTR genotype … what next?
28. Diagnose and treat paediatric-onset multiple sclerosis promptly to delay physical worsening and cognitive decline
29. Pimitespib: First Approval
30. Correction to: Baricitinib: A Review in Moderate to Severe Atopic Dermatitis
31. Amubarvimab/Romlusevimab: First Approval
32. Comparison of brain activation and functional outcomes between physical and virtual reality box and block test: a case study
33. Oteseconazole: First Approval
34. Baricitinib: A Review in Moderate to Severe Atopic Dermatitis
35. Palovarotene: First Approval
36. Tezepelumab: First Approval
37. Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy
38. Nusinersen: A Review in 5q Spinal Muscular Atrophy
39. Subcutaneous vedolizumab in moderately to severely active ulcerative colitis or Crohn’s disease: a profile of its use
40. Correction to: Contezolid: First Approval
41. Outdoor walking exhibits peak ankle and knee flexion differences compared to fixed and adaptive-speed treadmills in older adults
42. Wearable Sensor-Based Prediction Model of Timed up and Go Test in Older Adults
43. Rates, costs, return to work and reoperation following spinal surgery in a workers’ compensation cohort in New South Wales, 2010–2018: a cohort study using administrative data
44. A new roadmap for social medicine curriculum design based on mixed methods student and faculty evaluations of the preclinical curriculum
45. Contezolid: First Approval
46. Pegcetacoplan: First Approval
47. Correction to: Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use
48. Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use
49. Correction to: The design and implementation of a longitudinal social medicine curriculum at the University of Vermont’s Larner College of Medicine
50. The design and implementation of a longitudinal social medicine curriculum at the University of Vermont’s Larner College of Medicine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.